Stay updated on Talque & Teclistamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.

Latest updates to the Talque & Teclistamab Combo in Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.6.6 is now displayed on the page instead of Revision: v3.6.5, indicating a small platform update. This change affects only the page's version metadata and does not modify the study record.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a new version entry to the study history reflecting the latest Study Status update on 2026-07-20 (version 65). The entry also notes the Quality Control Review Has Not Concluded and the Returned date of 2026-08-11.SummaryDifference0.2%

- Check33 days agoChange DetectedA new revision tag, Revision: v3.6.5, is added to the page history, replacing Revision: v3.6.4. This reflects a backend update to the page without changing the study data.SummaryDifference0.0%

- Check55 days agoChange DetectedVersion 64 (Revision: v3.6.4) of the study record was added on 2026-07-15, with Quality Control Review Has Not Concluded. The new version brings in Adverse Events, Outcome Measures (Results), Contacts/Locations, Study Status, and Study Identification sections, reflecting updated trial information.SummaryDifference0.5%

- Check77 days agoChange DetectedA new revision tag, v3.6.3, was added to the page's history. The previous tag, v3.6.0, was removed.SummaryDifference0.0%

- Check91 days agoChange DetectedA recruitment status was updated to 'No longer looking for participants' with a returned date of 2026-06-12, and several study-result sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) were added alongside a Quality Control status. The record now shows Revision: v3.6.0 and notes the removal of the older v3.5.5, signaling an updated data review process.SummaryDifference0.7%

Stay in the know with updates to Talque & Teclistamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.